MODIFICATION
A -- Advanced and Innovative Solutions to Improve Public Health - Broad Agency Announcement - Amendment 1
- Notice Date
- 4/3/2018
- Notice Type
- Modification/Amendment
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- FY2018-OADS-BAA
- Archive Date
- 8/31/2018
- Point of Contact
- Eric A. Uhls, Phone: 7704882923
- E-Mail Address
-
kpy5@cdc.gov
(kpy5@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- FY2018 OADS Broad Agency Announcement instructions, as amended on April 3, 2018 The Centers for Disease Control and Prevention (CDC), the Office of the Associate Director for Science (OADS) issues this Broad Agency Announcement (BAA) for the Fiscal Year 2018 under the provisions of FAR 35.016 and FAR 6.102(d)(2) which provides for the competitive selection of research proposals. Contracts that are awarded based on responses to this BAA are as a result of full and open competition and therefore in full compliance with the provisions of PL 98-369, "The Competition in Contracting Act of 1984." CDC contracts with educational institutions, nonprofit organizations, state and local government, and private industry for research and development (R&D) in those areas covered in Part II of this BAA. The government reserves the right to make multiple awards under this announcement. This BAA establishes a four-step process for offerors contemplating submission of a proposal under this BAA. This sequence allows for an early determination of the potential for interest based on technical merit, applicability to CDC and projected funding. This process is designed to limit offeror and Government expenditure of effort to prepare and review formal proposals for research that may have little chance of being supported. Funding of research within CDC will be determined by funding availability and the following broad research priorities: 1) New Diagnostic, Sequencing, and Metagenomic Tools for AR Detection and Improved Antibiotic Use 2) International Transmission, Colonization, and Prevention of AR Pathogens 3) Domestic Transmission, Colonization, and Prevention of AR Pathogens and CDI 4) Develop Human Microbiome Disruption Indices Relevant to Antibiotic Resistance 5) Antibiotic Resistant Pathogens and Genes in Water Systems and the Environment and their Contribution to Human Infections 6) Improving Antibiotic Stewardship 7) Approaches to Prevention and Control of Parasitic Infections in the United States 8) Approaches to prevention and control of parasitic infections and neglected tropical diseases globally 9) Surveillance and Control of Arthropod Vectors of Human Pathogens 10) Modernization of the Surveillance Data Platform Interest/eligible applicants are instructed to seek further information and instructions for submission in the full BAA included in this posting.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/FY2018-OADS-BAA/listing.html)
- Record
- SN04875971-W 20180405/180403231315-e7915c6e7dd73cf4c0b7db0acc88fe20 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |